GCKR rs1260326 (minor allele: T) may prevent fibrosis in the nondiabetic state, but increases disease severity in the diabetic state, promoting NAFLD histological progression by affecting triglyceride levels, insulin resistance, DNL and mitochondrial function. Here, GCKR is linked to metabolic dysfunction-associated steatotic liver disease.